Archive for August 2011
Highlights of Recent Biomarker Patents
Posted by: sciclips on: August 30, 2011
1. N-terminal pyroglutamate modified MCP-1 as a biomarker for the diagnosis of inflammatory diseases 2. Biomarkers for measuring the effectiveness of a glutaminyl cyclase (QC) inhibitor 3. Phosphorylated cardiac Troponin I as a biomarker for the diagnosis of heart failure 4. Molecular diagnostic method for the detection of bacterial vaginosis 5. Biomarkers for the detection [...]
Recent Cancer Drug Discovery Patents
Posted by: sciclips on: August 29, 2011
Highlights of cancer drug discovery patent applications published on August 25, 2011: 1. Therapeutic drug target for increasing time to tumor recurrence in a cancer patient 3. Identification of14-3-3 protein inhibitors for the treatment of chronic myeloid leukemia 4. Serine threonine kinase inhibitors for treating hormone-refractory prostate cancer 5. CDK4/6 inhibiting pyrrolopyrimidine compounds for the [...]
Recent Drug Discovery Patent Highlights
Posted by: sciclips on: August 29, 2011
Highlights of the drug discovery patent applications (US) published on August 25, 2011: 1. Tetrazole compounds as uric acid transporter 1 (URAT1) inhibitors for the treatment of gout 2. Modified lecithin-cholesterol acyltransferase (LCAT) for the treatment of atherosclerosis 3. SPINK1 as a clinical target for prostate cancer 4. Serine threonine kinase inhibitors for treating hormone-refractory [...]
Recent Drug Discovery and Biomarker Research Highlights
Posted by: sciclips on: August 23, 2011
Drug discovery 1. Brain arachidonic acid cascade enzymes as therapeutic drug target for the treatment of Alzheimer’s disease 2. A real-time thallium flux HTS assay of human potassium channel opener 3. A simple assay for screening of protein kinase inhibitors in cell lysates 4. A label-free high-throughput mass spectrometry assay for rapidly screening epigenetic targets [...]
Recent Drug Discovery Patents
Posted by: sciclips on: August 22, 2011
1. MG53 as a therapeutic drug and a target for treating cardiac ischemia/reperfusion injury 2. Implantable pulse generator for treating sleep apnea 3. Antimycotics and prebiotics composition for the treatment of candidal vaginitis and vulvovaginitis 4. Method for preventing or treating a zoster-associated pain 5. Combination therapy for influenza viral infection 6. Immunostimulatory oligonucleotides for [...]
“Idea stealing”- does it affect scientific innovation and creativity?
Posted by: sciclips on: August 18, 2011
- In: Innovation
- 1 Comment
It is very interesting to note that “stealing others idea’ is a widely accepted common practice in research, both in academic and industrial laboratories. In a society where stealing, even petty things, is considered as a punishable crime, people steal ideas openly, without any hesitation, in academic and industrial organizations. Stealing expressions or ideas from [...]
Recent Drug Discovery Patents
Posted by: sciclips on: August 17, 2011
1. Growth hormone secretagogue receptor type 1A (GHS-R 1A) as a drug target for the treatment of anorexia 2. CGRP receptor antagonists for the treatment of headache, migraine and cluster headache 3. ESDN as a drug target for the treatment of restenosis after PTCA and arterial sclerosis 4. Mannitol based stable formulations of viruses and [...]
Recent Biomarker Patents
Posted by: sciclips on: August 15, 2011
1. Plasma biomarkers for the diagnosis of age-related macular degeneration 2. Methylene blue for semen quality diagnosis 3. Gene expression markers for distinguishing between active and latent Mycobacterium tuberculosis infection 4. Hypoxia-related genes as biomarkers for colon cancer or lung cancer 5. Exhaled breath condensate biomarker for the diagnosis of lung cancer 6. Urinary biomarkers [...]
Recent Drug Target Patents
Posted by: sciclips on: August 15, 2011
1. Combination therapy for Duchenne muscular dystrophy 2. TCPTP protein as a drug target for breast cancer treatment 3. Thienopyridinone 5-HT4 receptor modulators for the treatment of CNS disorders 4. Combination of PI3K inhibitor and mTOR inhibitor for the treatment of cancer 5. Mitochondrial permeability transition pore as a drug target of ischemia or neurodegenerative [...]
Recent Comments